The Evaluation of CD10 and HER2 Immunohistochemical Markers in Urothelial Carcinoma of Urinary Bladder
Background: Urothelial carcinoma (UC) has been considered the most frequent bladder tumor. Although the degree of bladder wall invasion and grade of the tumor are the essential prognostic factors in bladder carcinoma, there is no dependable parameter predicting patients’ outcomes. Objectives: To ass...
Saved in:
Main Authors: | Khalid W. Abdulfattah Khattab, Nadwa Subhi Alazzo, Banan Burhan Mohammed |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2024-12-01
|
Series: | Medical Journal of Babylon |
Subjects: | |
Online Access: | https://doi.org/10.4103/MJBL.MJBL_1615_23 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessment of Immuno-histochemical Expression of CD44 in Renal Tumors
by: Banan Mohammed, et al.
Published: (2025-01-01) -
Pathological features and immunohistochemical characteristics of clear cell (glycogen-rich) urothelial carcinoma: a case report and systematic review of the literature
by: Weiming Wang, et al.
Published: (2025-02-01) -
Application of immunohistochemical markers in mycosis fungoides
by: SHAO Kaixin, et al.
Published: (2025-01-01) -
Clinical significance of HER2 in urothelial carcinoma and analysis of its correlation with glycolytic metabolic characteristics
by: Andong Guo, et al.
Published: (2024-12-01) -
Predicting recurrence of non-muscle invasive bladder urothelial carcinoma: predictive value of the optimal cut-off value of Ki67
by: Rende Peng, et al.
Published: (2025-01-01)